Sweet's syndrome associated with sargramostim (Granulocyte-macrophage colony stimulating factor) treatment

American Journal of Hematology

Volumn 76, Issue 3, 2004, Pages 283-285

  Kumar, Geetika ^b   Bernstein, Jack M ^a,b   Waibel, Jill S ^b   Baumann, Michael A ^a,b,c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b WRIGHT STATE UNIVERSITY   (United States)

^c Medicine (111W)   (United States)

Author keywords

Granulocyte macrophage colony stimulating factor; Leukemia; Sweet's syndrome

Indexed keywords

CEFEPIME; CYTARABINE; PREDNISONE; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ACUTE FEBRILE NEUTROPHILIC DERMATOSIS; ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; BONE MARROW BIOPSY; CANCER IMMUNOTHERAPY; CASE REPORT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MYOSITIS; PRIORITY JOURNAL; SKIN BIOPSY;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOPSY; CYTARABINE; DAUNORUBICIN; GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTORS, RECOMBINANT; HUMANS; LEUKEMIA, MYELOCYTIC, ACUTE; MALE; MIDDLE AGED; PREDNISONE; REMISSION INDUCTION; SKIN; SWEET'S SYNDROME;

EID: 3042695148     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajh.20112     Document Type: Article

References (7)

1. Sweet RD. An acute febrile neutrophilic dermatosis. Br J Dermatol 1964;76:349-356.
2. Park JW, Mehrotra B, Barnet BO. Sweet's syndrome during therapy with granulocyte colony stimulating factor. Ann Intern Med 1992;116:996-998.
3. Christ E, Linka A, Jacky E, Speich R, Marincek B, Schaffner A. Sweet's Syndrome involving the musculoskeletal system during treatment of promyelocytic leukemia with all-trans-retinoic acid. Leukaemia 1996;10:731-734.
4. Paydas S, Sahin B, Zorludemir S. Sweet's syndrome accompanying leukemia: seven cases and review of the literature. Leuk Res 2000;24:83-86.
5. Gasson JC. Molecular physiology of granulocyte-macrophage colony-stimulating factor. Blood 1991;77:1131-1145.
6. Avalos BR. Molecular analysis of the granulocyte colony-stimulating factor receptor. Blood 1996;88:761-777.
7. Rowe JM, Andersen JW, Mazza JJ, et al. A randomized placebo-controlled phase III study of granulocyte-macrophage colony stimulating factor in adult patients (>55-70 years of age) with acute myelogenous leukemia: a study of the Eastern Cooperative Oncology Group (E1490). Blood 1995; 86:457-462.